EDIT-B®
Blood test to differentiate unipolar depression from bipolar disorder
EDITOX®
Cell-based solutions to mimic drug impact on RNA editing
EDITECH®
Integrated platform from RNA / DNA sequencing to machine learning and AI
Meet us
World Congress of Biological Psychiatry
From 9 to 12 September 2025 in Berlin
Our Scientific Director, Dr Dinah Weissmann, will present a poster on our research on the following topic: ‘RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar and Schizoaffective Disorders’, on 11 September at 6.15 p.m. (CET) & A symposium exploring precision psychiatry in the diagnosis of bipolar disorders will take place on 9 September.
Come and meet us!
Innovative Diagnostic Company
ALCEDIAG is an innovative diagnostic company specializing in the development and commercialization of blood tests, monitoring solutions, and companion diagnostics, primarily for mental health. These offerings are based upon the company’s distinctive expertise in epigenetics, RNA, and Artificial Intelligence, complemented by neurosciences and psychiatry.
ALCEDIAG’s unique approach is protected by seven patent families and supported by a global network of Key Opinion Leaders, who serve both as advocate for and early adopt of ALCEDIAG’s solutions.